Omada Health (NASDAQ:OMDA) CEO Sells 8,628 Shares

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 8,628 shares of Omada Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $21.85, for a total value of $188,521.80. Following the sale, the chief executive officer directly owned 411,861 shares in the company, valued at $8,999,162.85. The trade was a 2.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Stock Performance

Shares of NASDAQ:OMDA traded down $0.98 on Tuesday, hitting $24.01. The company’s stock had a trading volume of 1,906,414 shares, compared to its average volume of 1,272,868. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of 480.20 and a beta of 1.73. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The stock’s 50-day moving average is $20.49 and its two-hundred day moving average is $16.26.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. Equities analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OMDA. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Barclays raised their price objective on shares of Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Morgan Stanley restated an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research report on Monday, June 22nd. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Citigroup reiterated an “outperform” rating on shares of Omada Health in a research report on Monday, July 20th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $25.67.

Institutional Investors Weigh In On Omada Health

Institutional investors and hedge funds have recently bought and sold shares of the business. Perceptive Advisors LLC bought a new position in shares of Omada Health during the 2nd quarter valued at about $44,402,000. Millennium Management LLC raised its holdings in shares of Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares in the last quarter. BlackRock Inc. acquired a new stake in Omada Health during the second quarter valued at approximately $48,775,000. Loomis Sayles & Co. L P lifted its stake in Omada Health by 23.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock valued at $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Finally, Jefferies Financial Group Inc. bought a new stake in Omada Health during the fourth quarter worth approximately $16,948,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.